1 Reason the Meta Muse AI Agent Has the Upper Hand
Key PointsThanks to its massive ecosystem, Meta can indirectly generate ad revenue through its popular Muse AI agent.
Nasdaq Markets
Here's What History Says October Will Bring for Nike Stock
Key PointsNike's performance in October this decade has been a mixed bag.
Better Pharma ETF: iShares IHE vs. State Street XPH
Key PointsThe iShares U.S. Pharmaceuticals ETF is significantly more concentrated than the State Street SPDR S&P Pharmaceuticals ETF, with Eli Lilly accounting for 23.63% of the portfolio.
Here's the 1 Thing I'd Wait to See Before Buying SpaceX Stock.
Key PointsSpaceX’s AI losses are erasing Starlink’s profits.
Here's the Average Men's Social Security Benefit by Age
Key PointsThe average man's Social Security benefit was $2,282.28 as of December 2025.
Joby Just Flew an Aircraft Across the United States With No Pilot. Here's Why Wall Street Shrugged.
Key PointsJoby completed a 3,199-mile autonomous flight with zero pilot inputs.
Advanced Micro Devices vs. Qualcomm: Which Technology Stock Is a Better Buy in 2026?
Key PointsAdvanced Micro Devices is leveraging strategic partnerships with industry leaders to expand its footprint in the high-performance data center market.
Bitcoin ETF Inflows Are Soaring. But They Are Not Telling the Whole Story About What's Happening With Bitcoin.
Key PointsBitcoin ETFs have seen significant inflows in recent weeks.
The Best Stock to Invest $10,000 in Right Now
Key PointsDutch Bros grew Q2 revenue by 32% to $551 million, with same-shop sales up 8.3%, driven by real transaction growth rather than higher prices.
Could Buying This 1 Cryptocurrency Make You Rich?
Key PointsNEAR Protocol is up more than 230% for the year, making it a standout crypto performer in 2026.
Is SoundHound AI a Buy After the LivePerson Deal?
SoundHound AI (NASDAQ: SOUN) has a much larger enterprise opportunity after acquiring LivePerson. The critical question is whether OASYS can turn that expanded customer reach into cross-selling, higher recurring revenue, and improved economics before losses, declining legacy reve
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
Key PointsThe VanEck Biotech ETF and State Street SPDR S&P Pharmaceuticals ETF both carry an identical expense ratio of 0.35%.
Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?
Key PointsViking Therapeutics will soon enter phase 3 trials with its weight loss pill candidate.
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsBristol Myers Squibb provides high free cash flow and a deep oncology pipeline at a modest valuation.
AST SpaceMobile Has $3.7 Billion in Liquidity and No Commercial Revenue. Here's How to Value That.
Key PointsAST generates all of its revenue from defense contracts and commercial prepayments rather than continuous commercial contracts.
Why ExxonMobil's Venezuela Warning Could Matter for Energy Investors Right Now
Key PointsExxonMobil CEO Darren Woods famously called Venezuela “uninvestable.”
Star Bulk Carriers Director Karellis Purchases 2,000 Shares for $56,540. Is This a Signal The Cargo Rate Boom Continues?
Key PointsThe director acquired 2,000 shares at $28.27 per share for a total transaction value of $56,540.
Expectations of Another Fed Rate Hike This Month Are Shifting Dramatically
Key PointsThe futures market now sees a 20% chance of a rate hike at the late October meeting.
Cathie Wood Just Cut Her SpaceX Position. Is It Time to Sell?
Key PointsArk Invest estimates a $160 billion market opportunity in reusable rocket launchers.
Like Meta's Muse AI Agents? 4 AI Semiconductor Stocks Set to Benefit From the Rise of AI Agents.
Key PointsArm benefits from both its own CPUs and custom CPUs.
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed